Luigi Boccuto

5.2k total citations · 1 hit paper
125 papers, 3.3k citations indexed

About

Luigi Boccuto is a scholar working on Molecular Biology, Genetics and Epidemiology. According to data from OpenAlex, Luigi Boccuto has authored 125 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Molecular Biology, 48 papers in Genetics and 29 papers in Epidemiology. Recurrent topics in Luigi Boccuto's work include Genetics and Neurodevelopmental Disorders (23 papers), Genomic variations and chromosomal abnormalities (22 papers) and Liver Disease Diagnosis and Treatment (22 papers). Luigi Boccuto is often cited by papers focused on Genetics and Neurodevelopmental Disorders (23 papers), Genomic variations and chromosomal abnormalities (22 papers) and Liver Disease Diagnosis and Treatment (22 papers). Luigi Boccuto collaborates with scholars based in United States, Italy and Belgium. Luigi Boccuto's co-authors include Ludovico Abenavoli, Sara M. Sarasua, Emidio Scarpellini, Antonino De Lorenzo, Charles E. Schwartz, Nazarii Kobyliak, Francesco Luzza, Katy Phelan, Alka Dwivedi and Carmela Colica and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Luigi Boccuto

113 papers receiving 3.2k citations

Hit Papers

Gut Microbiota and Obesity: A Role for Probiotics 2019 2026 2021 2023 2019 100 200 300 400

Peers

Luigi Boccuto
Lining Guo United States
Hong Fang China
Ron Nudel Denmark
Daniel Rabinowitz United States
Hong Wei China
Luigi Boccuto
Citations per year, relative to Luigi Boccuto Luigi Boccuto (= 1×) peers Josep M. Mercader

Countries citing papers authored by Luigi Boccuto

Since Specialization
Citations

This map shows the geographic impact of Luigi Boccuto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luigi Boccuto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luigi Boccuto more than expected).

Fields of papers citing papers by Luigi Boccuto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luigi Boccuto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luigi Boccuto. The network helps show where Luigi Boccuto may publish in the future.

Co-authorship network of co-authors of Luigi Boccuto

This figure shows the co-authorship network connecting the top 25 collaborators of Luigi Boccuto. A scholar is included among the top collaborators of Luigi Boccuto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luigi Boccuto. Luigi Boccuto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Baldo, Giada Del, Andrea Carai, Antonella Cacchione, et al.. (2024). A second case report of medulloblastoma in a patient carrying biallelic pathogenic MUTYH germline variants. Neuropathology and Applied Neurobiology. 50(2). e12968–e12968.
2.
Mitz, Andrew R., Luigi Boccuto, & Audrey Thurm. (2024). Evidence for common mechanisms of pathology between SHANK3 and other genes of Phelan‐McDermid syndrome. Clinical Genetics. 105(5). 459–469. 8 indexed citations
3.
Farrell, Christopher, et al.. (2024). Impact of Substance Use Disorder on Tryptophan Metabolism Through the Kynurenine Pathway: A Narrative Review. Metabolites. 14(11). 611–611. 3 indexed citations
4.
Abenavoli, Ludovico, Rocco Spagnuolo, Giuseppe Guido Maria Scarlata, et al.. (2024). Metabolic Dysfunction-Associated Steatotic Liver Disease in Patients with Inflammatory Bowel Diseases: A Pilot Study. Life. 14(10). 1226–1226. 7 indexed citations
5.
Scarlata, Giuseppe Guido Maria, Luigi Boccuto, Carmela Colica, et al.. (2024). Dysmetabolic comorbidities and non-alcoholic fatty liver disease: a stairway to metabolic dysfunction-associated steatotic liver disease. Hepatoma Research. 10. 16–16. 15 indexed citations
6.
Scarlata, Giuseppe Guido Maria, et al.. (2024). The Role of Cytokines in the Pathogenesis and Treatment of Alcoholic Liver Disease. SHILAP Revista de lepidopterología. 12(4). 69–69. 5 indexed citations
7.
Pauly, Rini, et al.. (2024). PhenoMetaboDiff: R Package for Analysis and Visualization of Phenotype Microarray Data. Genes. 15(11). 1362–1362.
8.
Boccuto, Luigi, et al.. (2024). A Critical Review of the Impact of SMARCA4 Mutations on Survival Outcomes in Non-Small Cell Lung Cancer. Journal of Personalized Medicine. 14(7). 684–684. 8 indexed citations
9.
Abenavoli, Ludovico, Emidio Scarpellini, Giuseppe Guido Maria Scarlata, et al.. (2023). Gut Microbiota and Critically Ill Patients: Immunity and Its Modulation via Probiotics and Immunonutrition. Nutrients. 15(16). 3569–3569. 14 indexed citations
10.
Cacchione, Antonella, Andrea Carai, Giovanna Stefania Colafati, et al.. (2023). Safety and Efficacy of Mek Inhibitors in the Treatment of Plexiform Neurofibromas: A Retrospective Study. Cancer Control. 30. 2905562978–2905562978. 7 indexed citations
11.
Boccuto, Luigi, Jan Tack, Gianluca Ianiro, Ludovico Abenavoli, & Emidio Scarpellini. (2023). Human Genes Involved in the Interaction between Host and Gut Microbiome: Regulation and Pathogenic Mechanisms. Genes. 14(4). 857–857. 19 indexed citations
12.
Sarasua, Sara M., Jane M. DeLuca, Curtis Rogers, et al.. (2023). Head Size in Phelan–McDermid Syndrome: A Literature Review and Pooled Analysis of 198 Patients Identifies Candidate Genes on 22q13. Genes. 14(3). 540–540. 4 indexed citations
13.
Sarasua, Sara M., Linda Ward, William E. Bennett, et al.. (2023). Stratification of a Phelan–McDermid Syndrome Population Based on Their Response to Human Growth Hormone and Insulin-like Growth Factor. Genes. 14(2). 490–490. 3 indexed citations
14.
Abenavoli, Ludovico, Rocco Spagnuolo, Giuseppe Guido Maria Scarlata, et al.. (2023). Ultrasound Prevalence and Clinical Features of Nonalcoholic Fatty Liver Disease in Patients with Inflammatory Bowel Diseases: A Real-Life Cross-Sectional Study. Medicina. 59(11). 1935–1935. 18 indexed citations
15.
Agolini, Emanuele, Elena Botta, M. Cristina Digilio, et al.. (2021). Expansion of the clinical and molecular spectrum of an XPD ‐related disorder linked to biallelic mutations in ERCC2 gene. Clinical Genetics. 99(6). 842–848. 5 indexed citations
16.
Oberman, Lindsay M., Melanie May, Sujata Srikanth, et al.. (2021). Genetic and metabolic profiling of individuals with Phelan‐McDermid syndrome presenting with seizures. Clinical Genetics. 101(1). 87–100. 13 indexed citations
17.
Abenavoli, Ludovico, Tiziana Larussa, Anna Caterina Procopio, et al.. (2021). Dietary Polyphenols and Non-Alcoholic Fatty Liver Disease. Nutrients. 13(2). 494–494. 95 indexed citations
18.
Abenavoli, Ludovico, Luigi Boccuto, Alessandro Federico, et al.. (2019). Diet and Non-Alcoholic Fatty Liver Disease: The Mediterranean Way. International Journal of Environmental Research and Public Health. 16(17). 3011–3011. 102 indexed citations
19.
Dallio, Marcello, Nadia Diano, Mario Masarone, et al.. (2019). Chemical Effect of Bisphenol A on Non-Alcoholic Fatty Liver Disease. International Journal of Environmental Research and Public Health. 16(17). 3134–3134. 50 indexed citations
20.
Abenavoli, Ludovico, Tetyana Falalyeyeva, Luigi Boccuto, Olena Tsyryuk, & Nazarii Kobyliak. (2018). Obeticholic Acid: A New Era in the Treatment of Nonalcoholic Fatty Liver Disease. Pharmaceuticals. 11(4). 104–104. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026